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The structure of a C11 peptidase PmC11 from the gut bacte-
rium, Parabacteroides merdae, has recently been determined,
enabling the identification and characterization of a C11 ortho-
logue, PNT1, in the parasitic protozoon Trypanosoma brucei.A
phylogenetic analysis identified PmC11orthologues in bacteria,
archaea, Chromerids, Coccidia, and Kinetoplastida, the latter
being the most divergent. A primary sequence alignment of
PNT1 with clostripain and PmC11 revealed the position of the
characteristic His-Cys catalytic dyad (His99 and Cys136), and an
Asp (Asp134) in the potential S1 binding site. Immunofluores-
cence and cryoelectron microscopy revealed that PNT1 local-
izes to the kinetoplast, an organelle containing the mitochon-
drial genome of the parasite (kDNA), with an accumulation of
the protein at or near the antipodal sites. Depletion of PNT1 by
RNAi in the T. brucei bloodstream form was lethal both in in
vitro culture and in vivo in mice and the induced population
accumulated cells lacking a kinetoplast. In contrast, overexpres-
sion of PNT1 led to cells having mislocated kinetoplasts. RNAi
depletion of PNT1 in a kDNA independent cell line resulted in
kinetoplast loss but was viable, indicating that PNT1 is required
exclusively for kinetoplast maintenance. Expression of a
recoded wild-type PNT1 allele, but not of an active site mutant
restored parasite viability after induction in vitro and in vivo
confirming that the peptidase activity of PNT1 is essential for
parasite survival. These data provide evidence that PNT1 is a
cysteine peptidase that is required exclusively for maintenance
of the trypanosome kinetoplast.
Trypanosoma brucei is a kinetoplastid protozoan parasite
and the causative agent of human African trypanosomiasis
(sleeping sickness) and nagana in cattle. Sleeping sickness
causes widespread humanmorbidity and death in sub-Saharan
Africa. Nagana leads to cattle mortality, lower meat and milk
production, and lower calving rate. The parasite has a complex
life cycle spanning both the tsetse fly and the mammalian host.
The metacyclic trypomastigote is transmitted to the mamma-
lian host by the bite of the tsetse fly. Once inside the human
host, these parasites transform into bloodstream form (BSF)2
trypomastigotes that divide and multiply in blood and lymph,
and which is followed by invasion of the parasites to other
organs and the central nervous system. The sleep-wake cycle
gets disrupted and if the disease is left untreated, the infected
individual enters coma and eventually dies (1). Approximately
60 million people are at risk of being infected worldwide with
this disease (WHO fact sheetMay 2015). Currently no vaccines
are available and the drugs in use are becoming ineffective
and are toxic (2, 3). It is therefore imperative that new drug
targets are identified against the protozoan parasite.
Cysteine peptidases of parasitic protozoa are associated with
important biological processes such as, invasion of the host
cells (in case of intracellular parasites) and subsequent patho-
genesis (4, 5). Clan CD is comprised of peptidase families that
have a protein-fold similar to the caspase family (C14). ClanCD
is exemplified by several important cysteine peptidases such as
GPI8 (family C13), a component of the GPI-protein transami-
dase complex (6), metacaspase (family C14B) (7, 8), separase
(family C50) (9), and a relatively less characterized family C11
(clostripain) (10). In T. brucei the GPI-protein transamidase is
required for anchoring proteins to the plasma membrane.
Among these proteins the most prominent is variant surface
glycoprotein, which forms amonolayer on the parasites surface
and functions in the evasion of the immune system of the host
(6).T. bruceihas fivemetacaspases, includingMCA4,which is a
pseudopeptidase and virulence factor (11), andMCA2, which is
a calcium-dependent enzyme associated with RAB11 positive
endosomes and does not require processing for activation (12,
13). AnotherT. brucei cysteine peptidase, separase, functions in
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segregation of mini-chromosomes and proper mitotic assem-
bly (14).
Recently, the first crystal structure of a family C11 peptidase,
PmC11, was determined from the gut bacterium Parabacte-
roides merdae (15). This structure facilitated the identification
of an important T. brucei protein, PNT1 (Puf Nine Target 1) as
a C11 orthologue and a potential cysteine peptidase. The PNT1
transcriptwas previously described, in the insect procyclic form
of the parasite, as the target of the RNA-binding protein PUF9
(16), with PNT1 localizing to the kinetoplast, a unique organelle
containing the mitochondrial DNA of the organism. The kine-
toplast DNA (kDNA) of T. brucei is composed of a few dozen
maxicircles (23 kb) and several thousand minicircles (1 kb)
(17). The maxicircles encode essential mitochondrial proteins
including the respiratory chain complex subunits. The
minicircles encode guide-RNAs that function in editing the
RNAencoded by themaxicircles. The division of themitochon-
drial DNA is coordinated with cytokinesis (18) and the pres-
ence of essential genes on the kinetoplast makes it imperative
for each of the T. brucei progeny cells to inherit a kinetoplast
(19). Related species, Trypanosoma equiperdum and Trypano-
soma evansi, do not have a fully functional kinetoplast and are,
therefore, known as dyskinetoplastic (20). RNAi studies on kin-
etoplast regulatory genes have shown that loss of the kineto-
plast in T. brucei is lethal; hence, the organelle is considered an
important drug target (19, 21). Our functional analysis suggests
that PNT1 is a peptidase that plays an essential role in themain-
tenance of the kinetoplast, and that a catalytically active PNT1
is required for the survival of T. brucei. This work also demon-
strates that depletion of PNT1 leads to the generation of an
akinetoplastic cell line, whereas overexpression leads to forma-
tion of mislocated kinetoplasts thus, inhibitors of PNT1 could
be of interest for drug discovery programs.
Experimental Procedures
Phylogenetic Analysis—The peptidase C11 hidden Markov
model (HMM) profile (ACC PF03415.9) was obtained from
Pfam. The C11 peptidases are members of clan CD, a group
characterized by a doublet (H(G/A)) and triplet (D(A/S)C)
motif accounting for the catalytic histidine/cysteine dyad (22).
TheUniProtKBFASTA set (04/29/2015)was downloaded from
the UniProt site. This sequence set was searched for peptides
containing domains consistent with the model (conformant
proteins) by use of the HMM search program of HMMER3
using default parameters. The hits (full sequence E value
0.0001) were filtered as follows. Sequences from prokaryotic
and archaeal species were excluded; eukaryotic alignments
were examined and only those with at least a minimum align-
ment to the cysteine containing motif (D(A/S)C) retained. Full
peptide sequences for the identified eukaryotic sequences were
subsequently retrieved from UniprotKB; and a representative
sample of bacterial and archaeal C11 peptidase sequences were
obtained from the MEROPS database and added to the
sequence set.
The meta-method for assembling multiple sequence align-
ments was performed on the sequence set using the M-Coffee
(23) mode of T-Coffee (24). The output alignment (color coded
for alignment quality) was examined visually to determine the
domain containing the doublet (H(G/A)) and triplet (D(A/S)C).
The alignment was trimmed to this domain, and an HMMpro-
file generated (C11_euk), using the HMMER3 program hmm-
build. This HMM profile was used to search proteome sets
of a variety of eukaryotic genomes for C11_euk conformant
sequences. The domain sequences were extracted, the
sequence for metacaspase TbMCA2 (T. brucei Tb927.6.940,
MEROPS family C14, also in clan CD) was added as an out-
group and a multiple sequence alignment was generated as
above. Low quality (4) and low occupancy (30%) sites were
removed from the alignment and a neighbor-joining tree gen-
erated from the refined alignment (SplitsTree4 (25)).
Trypanosome Cell Culture—T. brucei 2T1 BSF cells were
maintained in HMI-9 medium supplemented with 10% FBS
(low TET, GIBCO), 100 unit ml1 of penicillin, 100 g ml1 of
streptomycin. The parasites were transfected as described (26)
and clones were obtained by limiting dilution. Appropriate
concentrations of antibiotics were used for the selection and
maintenance of the parasites: 2 g ml1 of puromycin, 2.5 g
ml1 of phleomycin, 5 g ml1 of hygromycin B, and 10 g
ml1 of blasticidin (all from InvivoGen). RNAi was induced
using 1 g ml1 of tetracycline. Cells were grown in 24-well
plates in triplicate for growth curve experiments.
Generation of the RNAi, Recoded and Myc-tagged PNT1
Constructs—A PNT1 RNAi construct (pTL232) was generated
using pGL2084, a gateway compatible version of pRPaSLi (27,
28). The oligonucleotides used for the generation of sense and
antisense PNT1 inserts for pTL232 were: OL4052, GGGGAC-
AAGTTTGTACAAAAAAGCAGGCTCGTCAGGACATGC-
TTGAAGA, and OL4053, GGGGACCACTTTGTACAAG-
AAAGCTGGGTTTTGCAATTCTTTCTGTGCG). pTL232
was digested with AscI and the stem loop cassette was trans-
fected in the bloodstream form of T. brucei 2T1. A recoded
gene (encoding mRNA that is refractory to RNAi) of PNT1was
designed in CLC genomics workbench (CLCbio) using the
codon usage table of T. brucei and subsequently synthesized by
GeneArt (Thermo Fisher Scientific). The recoded PNT1 gene
was cloned in-framewith aC-terminalHA tag in pGL2243 (29),
which integrates the gene of interest at the tubulin locus for
constitutive expression. Site-directed mutagenesis was carried
out on the recoded PNT1 to generate an active site recoded
mutant PNT1HAC136A. The mutations were carried out using
the QuikChange Site-directed Mutagenesis kit (Stratagene)
as per the manufacturer’s protocol. The identifiers of the
PNT1HA recoded and the mutated constructs were pGL2278
and pGL2320, respectively. The oligonucleotides used to gen-
erate the mutated recoded PNT1 were OL4280, CGATGGTT-
TTTGATAGTAGTTTCATGGCGAGCCTGG, and OL4281,
CCAGGCTCGCCATGAAACTACTATCAAAAACCATCG.
PNT1 was cloned in-frame in a tetracycline inducible C-Myc6
tag vector (pGL2220) (27) for generating a PNT1Myc cell line.
Transfection of the Parasites—1  107 log phase BSF cells
were suspended in 100 l of ice-cold Amaxa Human T-Cell
solution (Amaxa, Koeln, Germany) and transfection was car-
ried out according to the manufacturer’s protocol. Briefly, 10
g of linearized DNA plasmid was added to the cells and trans-
fected with the Amaxa Human Nucleofector II, using program
X-001. The cells were transferred to pre-warmed HMI 11
T. brucei C11 Cysteine Peptidase
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medium and plated out in 24-well plates at 1:20 and 1:40 dilu-
tions. The selection antibiotic was added after 6 h of transfec-
tion and cells were incubated at 37 °C. Transfectants were
selected after 1 week. F1FO-ATPase subunit L262P mutants
(20) were generated in the PNT1 RNAi cell line using gene
replacement constructs.3 Briefly, two rounds of transfections
were carried out to replace both the endogenous subunit 
alleles with L262Pmutant alleles. The cell lines were tested for
kDNA independence by treating with 10 nM ethidium bromide
for four passages, which resulted in generation of viable akin-
etoplastic cells.
Analysis of Trypanosome Growth after Induction of RNAi—
The PNT1 RNAi cell lines were seeded in triplicate at 1  105
cells per well in 24-well plates (HMI 11 hygromycin-phleomy-
cin media) in the presence and absence of tetracycline (1 g
ml1). The cell numbers were counted using a hemocytometer
every 24 h and cell seeded at 1  105 cells for the subsequent
time point. Infections inmice were carried out by initially inoc-
ulating a donor mouse with 1  105 parasites and monitoring
blood parasitemia over 72 h. Four experimental mice were
infected with 4  104 parasites harvested from the donor
mouse. Doxycycline was added to the drinking water of two of
the mice on the day of inoculation. Parasitemia in the blood of
the mice was calculated daily using a hemocytometer after
drawing the blood by tail venipuncture anddiluting the blood in
0.83% ammonium chloride. Cumulative growth curves were
plotted for the in vivo and in vitro cell counts using Prism6
(GraphPad software). The experiments were done in triplicate
for in vitro and in duplicate for in vivo experiments.
Real Time-PCR—2 105 BSF cells were grown for 24 h in the
presence and absence of tetracycline, harvested, and RNA was
prepared using the RNeasy kit (Qiagen). First strand cDNAwas
prepared using 4g of RNA for each sample (Invitrogen Super-
script: first strand synthesis kit). The cDNA was treated with
RNase H (Invitrogen) to degrade the template RNA. PCR was
performedusing SYBRGreenPCRmastermix (Applied Biosys-
tems) and GPI8 was used as an endogenous control. Oligonu-
cleotides OL4119, CACTTGGGTGGGCTCTCTTTC, and
OL4120, CAGCGGCTTCGACAATGG, were used for ampli-
fying PNT1, and OL2272, CGAAGCGCATTTGGATAGC,
and OL2273, AGCGCGTGATGACAGTGAAG, to amplify
GPI8. The quantitative PCR was run and analyzed on a 7300
Real-time PCR system (Applied Biosystems).
SDS-PAGE and Western Blotting of T. brucei Cell Lysates—
1  107 BSF parasites were lysed in sample buffer (NuPAGE
sample buffer) and analyzed on a 4–12% NuPAGE Novex Bis-
Tris gel usingMES buffer. Subsequently, the samples were elec-
troblotted on nitrocellulose membrane (GE Healthcare) and
probed with the respective antibodies. The PNT1HA cell line
was probed with anti-HA antibody (1:4000, Roche Applied Sci-
ence). The PNT1Myc cell line was probed with anti-Myc anti-
body (1:2000, Millipore). Anti-EF1 antibody (1:5000, Milli-
pore) was used for the loading controls.
Immunofluorescence—DAPI staining was carried out using
106 cells from exponential phase cultures. The cells were
washed with vPBS (22, 28), added to a 12-well glass slide
(Thermo Fisher) pre-coated in poly-L-lysine (0.1% (w/v) in
H2O, Sigma), and allowed to adhere for 4 min. Cells were fixed
with of 4% paraformaldehyde for 5min. The wells were washed
twice with PBS (pH 7.4) and excess paraformaldehyde was
quenched with 100 mM glycine for 10 min. The cells were per-
meabilized with 0.1% Triton X-100 for 10 min. The wells were
washed three times with PBS and overlaid with a drop of Slow-
Fade Gold Antifade Reagent with DAPI (Invitrogen). Cover-
slips were added and the slides were kept at 4 °C until required.
Staining of PNT1HAwas performed using 1 107 cells froman
exponential phase culture. The cells were resuspended in 200
l of PBS followed by addition of 300 l of 4% paraformalde-
hyde to fix overnight at 4 °C. The cells were washed with PBS
and resuspended in 100 mM glycine for 15 min. The cells were
then centrifuged at 600 g for 10min and resuspended in 0.1%
Triton X-100 (Sigma) for 5 min. Cells were washed twice with
PBS and incubated on ice for 1 h in 1% BSA (in PBS). The cells
were centrifuged for 600  g for 10 min and incubated with
anti-HA antibody (1:200, rat monoclonal, Roche) for 1 h on ice.
After washing with 0.1% BSA (PBS) cells were resuspended in
anti-rat Alexa 488 (1:2000, Molecular Probes) and incubated in
the dark on ice for 1 h. The cells were washed with 0.1% BSA
(PBS) before 0.5l of DAPI (100g/ml stock) was added to the
cells and incubated for 5 min. The cells were washed once with
0.1% BSA (PBS) and once with PBS. The final cell pellet was
resuspended in final volume of PBS (30–50 l) and stored at
4 °C until ready to image. The staining of the PNT1Myc cell line
was also carried out as described above using an anti-Myc anti-
body conjugated to Alexa Fluor 488 (Millipore) at 1:500 dilu-
tion. Stained cells were spread on a slide and overlaid with a
square coverslip. The images were acquired on a DeltaVision
Core microscope using excitation wavelength of 405–489 nm
and images were analyzed and processed in Adobe Photoshop
and FIJI.
Transmission Electron Microscopy—Cells were washed in
PBS, fixed with 2.5% glutaraldehyde and 4% paraformaldehyde
in 0.1 M sodium cacodylate buffer (pH 7.2), and post-fixed with
1% osmium tetroxide and 2.5% potassium ferrocyanide in 0.1 M
sodium cacodylate buffer (pH 7.3) for 45 min in the dark. Sam-
ples were en bloc stained with 2% aqueous uranyl acetate, dehy-
drated in a series of acetone solutions (30, 50, 70, 90, and 100%),
and finally embedded in Epon resin. Collected ultrathin sec-
tions were stained with lead citrate prior to observation in a
Tecnai T20 transmission electron microscope (FEI, Nether-
lands). All images were analyzed and processed in Adobe Pho-
toshop and FIJI (30). Acquired images were processed and the
intensity plot profile was acquired for kinetoplast density anal-
ysis. Statistical analyses were performed using Prism6, with
one-way analysis of variance analysis. Immunogold labeling of
cells was done by fixing cells overnight in 4% paraformaldehyde
in phosphate buffer, and dehydrating in ascending ethanol
solutions. The material was progressively infiltrated with LR
White resin, and polymerization was carried out in gelatin cap-
sules under ultraviolet light. Formvar-coated nickel grids with
ultrathin sections were incubated with blocking solution (3%
BSA, 0.02% Tween 20, in phosphate buffer, pH 8) for 1 h. The
grids were then incubated with the primary antibody anti-HA3 M. Gould and A. Schnaufer, unpublished data.
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(1:200 rat monoclonal, Roche) diluted in blocking buffer for 1 h
followed by several washes in blocking buffer. The grids were
then incubated with protein A conjugated to immunogold
(Aurion, Netherlands) for 1 h. After several washes with block-
ing buffer and phosphate buffer, the grids were stained with
uranyl acetate and lead citrate prior to observation in a Tecnai
T20 transmission electron microscope (FEI, Netherlands).
Results
Phylogeny of the C11 Cysteine Peptidase Family—To deter-
mine the phylogenetic distribution ofC11proteins, theUniProt
database was queried with a bespoke C11 HMM domain pro-
file. This analysis identified clostripain-like proteins in a wide
range of bacterial and archaeal species and in a limited range of
eukaryotic species, which could be divided into distinct clades
(branches) (Fig. 1A). One clade, containing a subset of species
from Chromerida, Coccidia, and Chlorophyta, is monophyletic
with the archaeal and bacterial species, as exemplified by
P. merdae PmC11 (15) and Clostridium histolyticum clostri-
pain, and suggests a lateral gene transfer event from a non-
eukaryotic species to a plastid-containing organism ancestral to
these phyla (31). The sparse distribution of the C11 domain is
indicative of frequent loss from genomes in successive rounds
of evolution, as there is no evidence of C11 proteins among
species of Babesia or Plasmodium, whereas C11 proteins are
found in other apicomplexan genera including Toxoplasma,
Eimeria, and Neospora. A second clade (kin) is present in kin-
etoplastids and is atypical in comparison to other eukaryotic
species and bacterial/archaeal domains. The C11 domain is
found in T. brucei (PNT1), Leishmania, and Bodo saltans, but
not in Phytomonas, Leptomonas, or Paratrypanosoma, indicat-
ing secondary loss of the PNT1 gene in kinetoplastid groups.
Active PNT1 Is Essential for T. brucei Viability—PNT1 is the
ortholog of PmC11 in T. brucei (Fig. 1A). A primary sequence
alignment of PmC11, clostripain, and PNT1 (Fig. 1B) led to the
identification of the conserved His-Cys catalytic dyad (His99
and Cys136, respectively). PmC11 is somewhat shorter than the
other two proteins but large sections of all three overlay well,
FIGURE1.Phylogenetic analysis of the clanCDC11peptidase family.A,unrootedneighbor joining treeof theC11 family frombacteria andarchaeal species
(Bact/Arch), Coccidia (Cocc), Chromerida (Chro), Chlorophyta (Chl), and Kinetoplastids (Kin; A, Trypanosoma; B, Leishmania/Endotrypanum/Crithidia; C,
Bodonida). Clostripain ()Uniprot ID P09870; PmC11(*)Uniprot ID, A7A9N3; and PNT1 (#)Uniprot ID, Q385B4 are marked. Key: 1, K2PE90 Trypanosoma cruzi. 2,
A0A061IWY5Trypanosomarangeli.3,F9W8X5Trypanosomacongolense. 4,Tb927.11.6550T. brucei.5,G0UBL1Trypanosomavivax.6,Q4QH06 Leishmaniamajor.
7, AOFS01001278.1 2 2 2134 Endotrypanum monterogeii. 8, CfaC1 13 0800 Crithidia fasciculata. 9, BS39455 B. saltans. 10, EQ973215 Bacteroides fragilis. 11,
GL883824 Paraprevotella xylaniphila. 12, AHHG01000029 Elizabethkingia anophelis. 13, P09870 C. histolyticum. 14, ADLW01000010 Dysgonomonas mossii. 15,
AE010299Methanosarcina acetivorans. 16, SNAP00000001341 Eimeria tenella. 17, B6ABJ5 Cryptosporidiummuris. 18, MER037012 Cryptosporidium parvum. 19,
Cvel 15101 Chromera velia. 20, A0A086LCT5 Toxoplasma gondii. 21, V4ZRY6 T. gondii. 22, F0VJH3 Neospora caninum. 23, U6G6U0 Eimeria praecox. 24,
MER494436 Vitrella brassicaformis. 25, D8TW66 Volvox carteri. 26, A8I9P1 Chlamydomonas reinhardtii. 27, A0A0D2MVH2 Monoraphidium neglectum. 28, NC
018015 Thermococcus sp. CL1. 29, ABYK01000024 Arthrospira maxima. 30, DS990529 Aciduliprofundum boonei. 31, A7A9N3 P. merdae. 32, AJ437303 T. brucei
MCA2 (outgroup). B, primary amino acid sequence alignment of PmC11 (from P. merdae), PNT1 (from T. brucei), and clostripain (from C. histolyticum) with
identical residues highlighted in gray shading. The assigned secondary structure from the crystal structure of PmC11 (15) ismappedonto its sequencewith the
position of the PmC11 catalytic dyad and autocatalytic cleavage site (Lys147) highlighted by a red star and a red triangle, respectively. Connecting loops are
colored gray/black, the main -sheet is in orange, with other strands in olive, -helices in blue, and the nonapeptide linker of clostripain underlined in red.
Sequences around the catalytic site of clostripain, PmC11, and PNT1 are aligned where identical residues are highlighted in gray.
T. brucei C11 Cysteine Peptidase
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covering most of the PmC11 residues with particularly good
alignment around the active site. This suggests that the second-
ary structural elements identified in PmC11 will form the core
structural elements of clostripain and PNT1.
Attempts to obtain soluble recombinant PNT1, for testing
protease activity in vitro, were unsuccessful. However, it was
possible to investigate peptidase activity and its importance in
parasite survival indirectly. Initially, aPNT1RNAi linewas gen-
erated in the BSF of T. brucei, where induction by tetracycline
resulted in loss of cell viability in the in vitro culture (Fig. 2A).
PNT1was also observed to be essential in vivowith doxycycline
induction leading to loss of detectable parasitemia inmice after
96 h (Fig. 2B).
To test whether catalytically active PNT1 is required for the
survival of the parasites, a recoded version of PNT1, containing
a C-terminal HA tag (PNT1HA, which is refractory to RNAi)
was constitutively expressed in thePNT1RNAi line. Expression
of the PNT1HA recoded protein compensated for the loss of
endogenous PNT1 and restored viability of tetracycline
induced parasites both in vitro culture (Fig. 2C) and in vivo (Fig.
2D). A cell line in which the recoded PNT1HA had the pre-
dicted active site cysteine mutated to serine PNT1HAC136S was
not viable after induction in vitro (Fig. 2E) and in vivo (Fig. 2F).
Quantitative RT-PCR confirmed the depletion of PNT1mRNA
in each of the cell lines (insets in Fig. 2,A,C, andE) andWestern
blotting confirmed that PNT1HAC136S was expressed at a sim-
ilar level to PNT1HA (Fig. 3A). Another interesting observation
from theWestern blots was the absence of processed fragments
of recoded PNT1HA suggesting that PNT1 might not require
processing for activity. This is in contrast to PmC11, which
requires intramolecular processing for full activation (15). This
observation is further supported by the primary sequence align-
ment of PNT1 with PmC11 and clostripain, where the cleavage
site Lys (Lys147) in PmC11 aligns with a reported cleavage site
Arg (Arg190) in clostripain (32), whereas in PNT1 there is anAla
at the equivalent position (Fig. 1B). Additionally, phylogenetic
analysis (Fig. 1A) shows that trypanosomatid C11 orthologues
are quite divergent from bacterial and archaea C11 family
members. These results suggest that PNT1 is different from
PmC11 in terms of activation and that the peptidase activity of
PNT1 is essential for viability of T. brucei.
PNT1 Localizes on the Kinetoplast—PNT1 localizes to the
kinetoplast in BSF parasites and was enriched either within or
near the antipodal sites, which are protein assemblies located
on opposite sides of the kDNA disc involved in minicircle rep-
lication (33, 34). This localizationwasmore prominent in divid-
ing kinetoplasts (Fig. 3B). Immunogold labeling of thePNT1HA
cell line confirmed that PNT1HA is located on the kinetoplast
(Fig. 3C, i and ii)). The status of the kinetoplast in PNT1-de-
pleted cells was investigated using TEM, which showed a lower
electron density of the kinetoplast in RNAi-induced cells com-
paredwith uninduced cells (Fig. 3, iii and iv). This indicates that
PNT1 depletion results in a reduction of material within the
kinetoplast. It has been demonstrated that RNAi-mediated
depletion of proteins closely associatedwith the kinetoplast can
cause the loss of kDNA (35, 36). To observe the effects of down-
regulating PNT1 on the number of nuclei and kinetoplasts, the
PNT1 RNAi line was stained with DAPI at different time points
after induction. Depletion of PNT1 by RNAi resulted in an
increased number of cells lacking a kinetoplast (akinetoplastic,
FIGURE 2.Growth of PNT1 RNAi cell lines in vitro and in vivo. A and B, PNT1 RNAi cell line. C and D, PNT1 RNAi cell line expressing recoded PNT1HA. E and F,
PNT1 RNAi cell line expressing recoded PNT1HAC136S. A, C, and E, representative growth curves show cumulative cell counts after induction of RNAi with
tetracycline in vitro (mean of three independent experiments) (inset, PNT1 mRNA depletion monitored by qRT-PCR). B, D, and F, 4 mice were inoculated
intraperitoneally with 4 104 parasites and RNAi was induced with doxycycline in 2 mice at the time of inoculation. Uninduced mice were culled when the
parasitemia levels were higher than 108 cells ml1. The parasitemia in blood samples were plotted over time.
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1N0K) after 2 days (Fig. 3D). The number of 1N0K cells
increased from 16% on day 2 to 46% on day 4, after RNAi induc-
tion. This increase in akinetoplastic cells suggests that PNT1 is
involved in the maintenance of the kinetoplast in T. brucei.
Interestingly, inducible overexpression of a Myc-tagged PNT1
(PNT1Myc) leads to formation of an additional kinetoplast
anterior to the nucleus, a phenotype similar to that observed in
the procyclic form of T. brucei (16). In addition, 36% of the
induced PNT1Myc cell line had a mislocated kinetoplast after
48 h of induction (Fig. 4, A and B). PNT1 was also localized on
these incorrectly positioned kinetoplasts (Fig. 4B, lower panel).
Overexpression of PNT1 led to an increase of 1N2K cells
from 12 to 39% after 24 h of induction, compared with 12%
observed in uninduced cells (Fig. 4C). However, the number of
1N2K cells in the induced culture decreased to 14 and 8% at 48-
and 72-h time points, respectively. The T. brucei cell cycle is a
well coordinated event in which the kinetoplast is placed pos-
terior to the nucleus during cytokinesis. In cells overexpressing
PNT1, mislocated kinetoplasts found anterior to the nucleus
were observed in cells at all stages of the cell cycle. The decrease
in the number of kinetoplasts might be due to continuous cyto-
kinesis of cells having mislocated kinetoplasts. PNT1 overex-
pression by tetracycline induction also leads to loss of cell via-
bility in BSF T. brucei (Fig. 4D). Importantly, cell death is
observed when PNT1 is either down-regulated or overex-
pressed, indicating that an optimal amount of PNT1 peptidase
activity is essential for viability of the parasite.
PNT1 Is Required Exclusively for Maintenance of the
Kinetoplast—A kinetoplast-independent PNT1 RNAi cell line
was generated to investigate whether PNT1 is required exclu-
sively for kinetoplast maintenance or whether it has other
essential mitochondrial functions. It has recently been demon-
strated that an L262P mutation in the F1 subunit of the F1F0-
ATPase complex allows BSFT. brucei to survive loss of the kin-
etoplast (20). ThePNT1RNAi linewasmodified to replace both
of the wild-type  alleles with L262P mutant alleles. The PNT1
RNAi was then induced with tetracycline. No growth defect
was observed after induction (Fig. 5A, left panel) despite greater
than 90%depletion of thePNT1 transcript (Fig. 5A, right panel).
Additionally, depletion of PNT1 resulted in a 100%akinetoplas-
tic cell population after 4 days of induction. Thus, PNT1 is
redundant in the absence of a requirement for the kinetoplast
for cell viability (Fig. 5B). Taken together, these data indicate
that PNT1 is exclusively required for kinetoplast maintenance
and becomes redundant in the absence of a cellular require-
ment for the organelle.
Discussion
The structure of a bacterial C11 protein (PmC11) (15)
allowed the catalytic dyad of the PNT1 orthologue to be iden-
tified and probed. Despite being larger than PmC11, a basic
primary sequence alignment suggests that the secondary struc-
tural elements identified in PmC11will form the core structural
elements of PNT1 (Fig. 1B). Our data and others (16) indicate
FIGURE 3. Phenotype analysis of PNT1 RNAi, PNT1HA, and PNT1Myc cell lines. A, expression of recoded PNT1HA in the PNT1 RNAi cell line. Lysates of PNT1
RNAi cells expressing recoded PNT1HA (lanes 1 and 2) or recoded PNT1HAC136S (lanes 3 and 4) before (lanes 1 and 3) and after (lanes 2 and 4) tetracycline
induction were immunoblotted and probed with anti-HA antibody. EF1 was used as loading control. B, immunofluorescence of PNT1HA expressed in
tetracycline induced PNT1 RNAi cell line (lower panel) shows localizationwithin or near antipodal sites. Uninduced PNT1 RNAi cell lines (upper panel) were used
as a control. The cells were stained with anti-HA antibody (green) and DAPI (blue). A stained, nearly duplicated kinetoplast (yellow box) is shown in magnified
view. Scale bar, 5 m. C, i and ii, immunogold labeling of PNT1HA cell line using anti-HA antibody after 72 h of RNAi induction. Scale bar, 100 nm. iii and iv,
electronmicrographsofPNT1RNAiuninduced (iii) and72h tetracycline-induced (iv) cells (scale bar, 150nm).D, PNT1RNAi cells inducedwith tetracycline (Tet)
were stained with DAPI and the number of nuclei (N) and kinetoplasts (K) per cell was counted (in 200 cells) at the indicated time points and plotted as a
percentage of the total. Each histogram represents mean S.D. (n 3).
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that PNT1 is present at the ends of the kinetoplast, which could
be the antipodal sites where newly replicated minicircles reat-
tach to the network for repairing discontinuities during repli-
cation (such as gap filling and ligation) (37, 38). Several proteins
have been identified at the antipodal sites of the kinetoplast
including helicases (33, 39), a minicircle origin binding protein
p38 (40), DNA polymerase  (41), and a DNA primase PRI1
(42), among others. Depletion of p38 (40), PIF8 (33), and PRI1
(42) also result in loss of kDNA, a similar phenotype to PNT1
depletion; however, there is no evidence to suggest that these
proteins require proteolytic processing, whereas it is the pepti-
dase activity of PNT1 that is essential. To date, only one other
FIGURE 4. Overexpression of PNT1. A, upper panel, Western blot showing expression of PNT1Myc using anti-Myc antibody at different time points after
tetracycline induction (lanes 2–4 represent inducedsamples after 24, 48, and72h, respectively). A24-huninducedPNT1Myc sample in lane1 servedasnegative
control. EF1was used as the loading control. Lower panel, percentage of cells having anterior kinetoplasts after tetracycline induction at different time points
(quantitation from 200 cells, histogram represents mean S.D. (n 3)). B, representative images showing the DAPI-stained, PNT1Myc-tagged cell line before
(top panel) and after (middle panel) induction with tetracycline for 24 h. Bottom panel, staining of the PNT1Myc cell line with anti-Myc antibody conjugated to
Alexa Fluor 488 (green). Scale bar, 5m. C, counts of DAPI-stained kinetoplast (K) and nuclei (N) of the PNT1Myc cell line showing a higher percentage of 1N2K
cells at 24 h after induction. The number of 1N2K cells fall after 48 and 72 h (n 3, mean S.D.). D, cumulative growth curve of PNT1Myc cell line showing
reduced cell viability after PNT1 overexpression.
FIGURE5.PNT1 isexclusively required forkinetoplast function.A, left panel, cumulativegrowthcurveofPNT1L262PRNAi lineover time tetracycline (n
3). Right panel, the mRNA levels of PNT1 transcript were evaluated in the induced and uninduced PNT1L262P RNAi cell line using quantitative RT-PCR. Each
histogram represents themean S.D. (n 3). B, loss of kinetoplast in the PNT1L262P RNAi cell line after addition of tetracycline to down-regulate PNT1. The
cells were grown for 120 h tetracycline and stained with DAPI. Scale bar, 5 m.
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protease, HslVU (43), has been found to regulate kDNA main-
tenance in T. brucei. Unlike PNT1, down-regulation of HslVU
leads to over-replication of minicircles and formation of large
kDNA networks. Moreover, HslVU localizes throughout the
mitochondrion, suggesting that HslVU could have other roles
in the organelle, whereas PNT1 is required exclusively for
kDNA maintenance. The appearance of an additional kineto-
plast in an abnormal position observed after PNT1 overexpres-
sion is reminiscent of the ”ancillary“ kinetoplasts reported after
ablation of, DNA polymerase IC (44) or the acyl carrier protein
(45), and of those observed in candidate gametes of T. brucei
(46). Phylogenetic analysis of PNT1 orthologues suggests that
kinetoplastid PNT1 genes are very divergent from orthologues
of other organisms. The sequence alignment of PNT1 with
PmC11 revealed the presence of conserved structural elements,
but also showed novel elements indicating that they have
evolved to perform some kinetoplastid-specific function. Not
all kinetoplastids have PNT1; Phytomonas and Leptomonas
appear to lack a PmC11 orthologue, which might indicate that
there are alternative regulatory mechanisms for kDNA replica-
tion in these organisms. It is also interesting to note that
T. evansi and T. equiperdum have a PNT1 gene, even though
these organisms are dyskinetoplastic (47). It is possible that
PNT1 is required for maintenance of minicircles in these
organisms, although there are no data currently to support this
hypothesis. Further work on the identification of PNT1 sub-
strateswould provide exciting new insights into themechanism
of kinetoplast replication and segregation in T. brucei as well as
guiding inhibitor and possibly drug discovery.
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